EISAI CO.LTD.;ARENA PHARMACEUTICALS INC.;EISAI R & D MANAGEMENT CO. LTD.
发明人:
申请号：
IL22482913
公开号：
IL224829A
申请日:
2013.02.20
申请国别(地区):
IL
年份:
2019
代理人:
摘要：
The present invention relates to methods for weight management that utilize modified-release dosage forms comprising ( R )-8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H -3-benzazepine salts and crystalline forms thereof. The present invention further relates to ( R )-8-chloro-1-methyl-2,3,4,5-tetrahydro-1 H -3-benzazepine salts, crystalline forms thereof and modified-release dosage forms comprising them.
